Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-022930
Filing Date
2016-06-15
Accepted
2016-06-15 16:15:21
Documents
1
Period of Report
2016-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3945
  Complete submission text file 0000899243-16-022930.txt   5314
Mailing Address ALLOS THERAPEUTICS, INC. 11080 CIRCLEPOINT ROAD, SUITE 200 WESMINSTER CO 80020
Business Address
HOFFMAN STEPHEN J (Reporting) CIK: 0001190418 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 161715436

Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations